https://www.selleckchem.com/products/at13387.html
odicals, Inc.Autologous stem cell transplantation (ASCT) is feasible and effective in selected older patients with Multiple Myeloma but specific criteria for evaluating ASCT eligibility in elderly patients are lacking. We evaluated 131 patients aged 65-75 considered for ASCT at our center Charlson Comorbidity Index (CCI), Hematopoietic cell transplantation comorbidity index (HCT-CI) and IMWG frailty score were obtained at diagnosis, but the intensity of treatment was left to physician's choice. The scores and age's impact on outcome was
Like
Comment
Share
